![Albert Saporta](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Albert Saporta
Presidente presso
Stallergenes Ibérica SA
Profilo
Albert Saporta is currently the Chairman at Stallergenes Ibérica SA, the Non-Executive Chairman at ASAP France SARL, the Director at Stallergenes Italia Srl, the Director at Alergovet SA, the Director at Stallergènes Sp zoo, the Director at Stallergenes, Inc., and the President & Director at Fabentech SAS. Previously, he served as the Chairman at Stallergenes Belgium SA from 2004 to 2012, the Chairman at Stallergenes AG, the Director at Stallergenes SA from 1999 to 2014, the Independent Director at Hybrigenics SA from 2012 to 2019, the Head-European Operations at Pasteur Merieux Serums et Vaccins SA, the Chief Investment Officer at Alternative Investment Management & Research SA, the Head-International Development at Pasteur Mérieux Connaught, and the Chief Financial Officer at Institut Mérieux SA.
Posizioni attive di Albert Saporta
| Società | Posizione | Inizio |
|---|---|---|
Stallergenes Ibérica SA | Presidente | 26/07/2010 |
Alergovet SA | Direttore/Membro del Consiglio | 26/07/2010 |
Stallergènes Sp zoo | Direttore/Membro del Consiglio | 01/01/2011 |
Stallergenes Italia Srl
 Stallergenes Italia Srl Medical DistributorsDistribution Services Wholesales pharmaceutical products | Direttore/Membro del Consiglio | 01/01/2009 |
Stallergenes, Inc. | Direttore/Membro del Consiglio | 01/01/2011 |
Fabentech SAS
 Fabentech SAS Medical/Nursing ServicesHealth Services Developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. | Presidente | - |
ASAP France SARL | Presidente | - |
Precedenti posizioni note di Albert Saporta
| Società | Posizione | Fine |
|---|---|---|
| ATON | Direttore/Membro del Consiglio | 14/10/2019 |
| STALLERGENES | Presidente | 13/01/2012 |
| ░░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░ ░░░░░░ ░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
32
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Pasteur Merieux Serums et Vaccins SA
 Pasteur Merieux Serums et Vaccins SA BiotechnologyHealth Technology Operates a biomedical group | Health Technology |
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products used for the treatment of allergy-related respiratory diseases | Health Technology |
Hybrigenics SA
 Hybrigenics SA Pharmaceuticals: MajorHealth Technology Develops therapeutic molecules and genomics | Health Technology |
Alternative Investment Management & Research SA
 Alternative Investment Management & Research SA Alternative Investment Management & Research SA (AIM&R) is an alternative research and investment management firm which was founded in 1995 by Albert Saporta. Located in Geneva, Switzerland, AIM&R manages the S.O.G. Fund and SOGAsia hedge funds and managed accounts for sophisticated investors. In 2003 the firm formed a strategic alliance with United Overseas Bank Ltd., Singapore, through their subsidiary UOB Global Capital LLC, for the exclusive worldwide distribution of the SOGAsia Fund. AIM&R also advises hedge funds and trading groups. | |
Pasteur Mérieux Connaught | |
Institut Mérieux SA
 Institut Mérieux SA BiotechnologyHealth Technology Provides solutions for multifactorial management of diseases | Health Technology |
Stallergenes Ibérica SA | Distribution Services |
Stallergenes Italia Srl
Stallergenes Italia Srl Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Stallergenes Belgium SA
 Stallergenes Belgium SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products used for the treatment of allergies | Health Technology |
Alergovet SA | |
Stallergenes AG
 Stallergenes AG Pharmaceuticals: OtherHealth Technology Engages in the manufacture and distribution of products in the medical, diagnostic, and cosmetic fields | Health Technology |
Stallergènes Sp zoo | |
Stallergenes, Inc. | |
Fabentech SAS
Fabentech SAS Medical/Nursing ServicesHealth Services Developes immunotherapeutic solutions for emerging infectious diseases as well as for certain drug intoxications. | Health Services |
ASAP France SARL |
